Tag: ZSAN News


Zosano Pharma Corp (NASDAQ: ZSAN) Announces Issuance of U.S. Patent for Acute Treatment of Migraine with M207

Zosano Pharma Corp (NASDAQ: ZSAN), a biopharmaceutical firm, announced that it had been granted the patent covering a method of M207 titled ‘Method of Rapidly Achieving Therapeutic Concentrations of Triptans for the Treatment of Migraines’ with the issuance of United States Patent No. 11,058,630.  Steven Lo’s Statement Steven Lo, President […]